Related Experiment Video
Updated: Dec 6, 2025

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
Published on: October 25, 2024
Antithrombotic Agent Use in Elderly Patients Sustaining Low-Level Falls.
Michael J Meade1, Abhinay Tumati1, Chanak Chantachote1
1Division of Trauma, Department of Surgery, Stony Brook University School of Medicine, Stony Brook, New York.
Elderly fall patients on antithrombotic agents, including anticoagulants and antiplatelets, have a higher risk of intracranial hemorrhage (ICH). Anticoagulant use in these patients is also linked to increased mortality.
Area of Science:
- Geriatric Trauma
- Pharmacology
- Neurological Surgery
Background:
- Elderly patients experiencing low-level falls represent a growing segment of trauma admissions.
- Evaluating antithrombotic agent use, injury patterns, and outcomes in this demographic is crucial, with a specific focus on intracranial hemorrhage (ICH).
Purpose of the Study:
- To determine the prevalence of antithrombotic agent use in elderly patients admitted after low-level falls.
- To analyze injury patterns and patient outcomes, particularly the incidence of ICH.
- To assess the association between antithrombotic use and ICH, as well as mortality rates.
Main Methods:
- Retrospective review of trauma registry data from 2007-2016 at a Level I trauma center.
- Inclusion criteria: patients aged 65 or older admitted following a low-level fall.
- Data analysis involved comparing outcomes between patients on and not on antithrombotic agents, stratified by ICH presence.
Main Results:
- Of 4074 elderly fall patients, 1153 (28.3%) had ICH and 1238 (30.4%) were on antithrombotics.
- Patients on antithrombotics had a significantly higher rate of ICH (35.9%) compared to those not on these agents (25.0%).
- Antithrombotic use, especially anticoagulants, was associated with higher mortality rates in patients with ICH.
Conclusions:
- Antithrombotic agent use is prevalent in elderly patients admitted for low-level falls and is associated with an increased risk of ICH.
- Anticoagulant use in this population is a significant risk factor for both ICH and increased mortality.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Drug Dosing: Geriatric Patients
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacodynamics in Geriatric Patients: Effects of Age

